+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cellular Immunotherapy"

Cellular Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Cellular Immunotherapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
CAR-T Therapy Global Market Report 2024 - Product Thumbnail Image

CAR-T Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
TIL therapy - Pipeline Insight, 2024 - Product Thumbnail Image

TIL therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Global Cancer Immunotherapy Market Outlook 2027 - Product Thumbnail Image

Global Cancer Immunotherapy Market Outlook 2027

  • Report
  • October 2018
  • 370 Pages
  • Global
From
From
From
From
Immuno-oncology Development Trends and Opportunities - Product Thumbnail Image

Immuno-oncology Development Trends and Opportunities

  • Report
  • November 2018
  • 258 Pages
  • Global
From
Liver Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Liver Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 73 Pages
  • Global
From
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2019 - Product Thumbnail Image

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 80 Pages
  • Global
From
T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019 - Product Thumbnail Image

T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 73 Pages
  • Global
From
Cancer Testis Antigen 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Cancer Testis Antigen 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 76 Pages
  • Global
From
From
Loading Indicator

Cellular Immunotherapy is a type of Immune Disorders Drugs that uses a patient's own immune cells to treat diseases. It is a form of personalized medicine that is tailored to the individual patient's needs. It works by stimulating the patient's own immune system to recognize and attack cancer cells or other diseased cells. It can also be used to treat autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis. Cellular Immunotherapy is a rapidly growing field, with many companies developing new treatments and technologies. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing new treatments for immune disorders. Other companies, such as Celgene, are also researching and developing new treatments for immune disorders. Additionally, many universities and research institutions are conducting research into the potential of Cellular Immunotherapy. Show Less Read more